Expand VYGR Menu
VYGR MENU

VYGR Stock Summary and Trading Ideas (Voyager Therapeutics | NASDAQ:VYGR)

Charts for Today's Stock Price and Implied Volatility in Voyager Therapeutics

18-Apr-2024

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for VYGR by Theoretical Edge and Win Rates

Sentiment

News

Trading Statistics

Key Ratios

Voyager Therapeutics (VYGR) Frequently Asked Questions

What does Voyager Therapeutics do?

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

What symbol and exchange does Voyager Therapeutics stock trade?

Voyager Therapeutics trades on the NASDAQ stock market under the symbol VYGR.

What is Voyager Therapeutics stock price doing today?

As of April 18, 2024, VYGR stock price declined to $7.55 with 986,999 million shares trading.

What is Voyager Therapeutics's Beta?

VYGR has a beta of 1.04, meaning it tends to be more sensitive to market movements. VYGR has a correlation of 0.04 to the broad based SPY ETF.

How much is Voyager Therapeutics worth?

VYGR has a market cap of $419.71 million. This is considered a Small Cap stock.

How much money does Voyager Therapeutics make?

Last quarter Voyager Therapeutics reported $90 million in Revenue and $1.25 earnings per share. This beat revenue expectation by $69 million and exceeded earnings estimates by $1.54.

What is the highest and lowest price Voyager Therapeutics traded in the last 3 year period?

In the last 3 years, VYGR stock traded as high as $14.34 and as low as $2.46.

What are the top ETFs holding Voyager Therapeutics?

The top ETF exchange traded funds that VYGR belongs to (by Net Assets): VTI, XBI, VXF, IWM, AVUV.

Is Voyager Therapeutics (VYGR) a good investment?

VYGR has underperformed the market in the last year with a price return of -3.5% while the SPY ETF gained +22.2%. VYGR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +3.7% and -17.3%, respectively, while the SPY returned +5.2% and -2.6%, respectively.

What is the support and resistance for Voyager Therapeutics (VYGR) stock price?

VYGR support price is $7.39 and resistance is $8.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VYGR stock will trade within this expected range on the day.